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important investigation to confirm prenatal diagnosis and 
aids in future counselling. This study has the limitation that 
autopsies could not be performed to confirm the diagnosis 
after the termination of pregnancy. We recommend that 
early ultrasound should be used to complement the 18-23 
weeks scans as the natural history of certain abnormalities 
does not allow early diagnosis. 
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Variability in Lipid Profile in Patients with Acute Myocardial Infarction from two 
tertiary care hospitals in Pakistan 
M. P. lqbal, M. Shafiq, N. Mehboobali, S. P. lqbal, K. Abbasi 
Department of Biological and Biomedical Sciences, The Aga Khan University, Karachi. 
Abstract 
Objective: To investigate changes in total cholesterol, high density lipoprotein (HDL)-cholesterol, low density 
lipoprotein (LDL)-cholesterol and triglycerides in serum of Pakistani patients with AMI due to age, gender, body 
mass index (BMI), diabetes, hypertension, and smoking, and also find out the prevalence of 
hypercholesterolemip, hypertriglyceridemia, "low HDL-cholesterol" and "isolated low-HDL cholesterol" in them. 
Patients and Methods: Serum samples from 451 consecutive AMI patients (250 from National Institute of 
Cardiovascular Diseases, K4rachi and 201 from Armed Forces Institute of Cardiology, Rawalpindi) were 
analyzed for total cholesterol, HDL-cholesterol and triglycerides using kit methods. LDL-cholesterol was 
determined using the Friedewald formula. 
Results: Mean serum concentrations of total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides in 
AMI patients were found to be 181 ± 50 mg/dl, 35.7 ± 11.3 mg/dl, 110 ± 47 mg/dl and 177 ± 127 mg/dl, 
respectively. Mean levels of total cholesterol and HDL-cholesterol were not significantly affected by age, gender, 
BMI, diabetes mellitus, hypertension and smoking. Mean LDL-cholesterol concentration, however, was found to 
be significantly increased in diabetes mellitus (p=0.047), while age, gender, BMI, hypertension and smoking had 
no significant effect on the levels of this lipoprotein. Mean levels of triglycerides were significantly decreased in 
older patients (>50 years) compared to younger (<50 years) ones (p=0.019). Gender, BMI, diabetes mellitus, 
hypertension and smoking, however, had no effect on triglyceride levels The frequencies of 
hypercholesterolemia, hypertriglyceridemia, "low HDL-cholesterol" and "isolated low-HDL-cholesterol" were 
found to be 30.6%, 30.1%, 48.6% and 34.1%, respectively. 
Conclusion: High prevalence of hypertriglyceridemia and low HDL-cholesterol (which constitute a component 
of metabolic syndrome) in Pakistani AMI patients is suggestive that these two lipid abnormalities could be playing 
a major role in the development of atherosclerosis in Pakistani population (JPMA 54:544;2004). 
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Introduction 
Disorders in lipid metabolism (dyslipidemia) can 
result in premature atherosclerosis', leading to the 
development of cardiovascular disease (CVD).' It has 
recently been pointed out that there is an epidemic of CVD 
in urban South Asians.2 Pakistanis being part of this ethnic 
group have very high rates of coronary artery disease 
(CAD).3 
 According to official estimates CVD results in 
more than 100,000 deaths every year4, however, the actual 
figure may even be much higher than that. Several large 
scale clinical trials have shown that lipid lowering 
interventions are associated with reduced coronary events 
and mortality.5 
 This shows the significance of determining 
the lipid status of CAD patients in order to reduce any 
further coronary events in them. 
With the exception of a couple of reports, there is 
hardly any published data on variability of lipid profile in 
Pakistani patients with acute myocardial infarction (AMI).6 
The present study was undertaken to investigate changes in 
lipid profile in Pakistani patients with AMI due to age, 
gender, body mass index (BMI), diabetes mellitus, 
hypertension and smoking, and also find out the prevalence 
of hypertriglyceridemia, low-HDL-cholesterol (both of 
these constitute an important component of metabolic 
syndrome), hypercholesterolemia and "isolated low-HDL 
cholesterol" in a population from two tertiary care hospitals. 
Patients and Methods 
A total of four hundred and fifty one consecutive 
patients with AMI (age 30-75 years) admitted to the 
National Institute of Cardiovascular Diseases (NICVD), 
Karachi from January 2001 to June 2001 (n=250) and the 
Armed Forces Institute of Cardiology, Rawalpindi from 
August 2003 to September 2003 (n=201) were included in 
this study. All of them had first acute attack of myocardial 
infarction. 
They had the confirmed diagnosis of AMI on the 
basis of WHO criteria of clinical history suggestive of 
myocardial ischaemia, ECG changes of myocardial damage 
and elevation of biochemical markers (creatine kinase and 
creatine kinase MB). All the patients were assessed for risk 
factors such, as, diabetes mellitus, hypertension, BMI, 
smoking etc. using the criteria given below. All those 
patients who were pregnant, having malabsorption 
syndrome, suffering from tuberculosis, liver disease, 
uremia, cancer or using vitamin B-complex supplements 
during the past 6 months were not included in this study. 
The study was approved by the Ethical Review Committee 
of the Aga Khan University. 
Criteria for diabetes were set as an abnormal fasting 
blood sugar level >125 mg/dl at admission, or having taken 
hypoglycemic agents for already established diabetes. All 
those with systolic blood pressure greater than 140 mmHg 
and/or diastolic blood pressure of 90 mmHg or those on 
regular anti-hypertensive medications were classified as 
hypertensive. Those who were smoking cigarettes or "beeri' 
regularly (one or more per day) were classified as smokers, 
 
A body mass index of greater than 25 was classified as 
overweight/obese. 
Hypercholesterolemia: Serum cholesterol level >200 
mg/d1. 
Hypertriglyceridemia: Serum triglyceride level >200 
mg/dl. 
Low HDL-cholesterol: Serum HDL-cholesterol level <35 
mg/d1. 
Isolated low HDL-cholesterol: Serum HDL-cholesterol 
level < 40 mg/dl and serum triglyceride level <150 mg/dl. 
Five ml venous blood was collected from patients 
within 24 hours of AMI and immediately transferred to 
plain tubes. After clotting, the serum was separated by 
centrifugation and stored frozen at -60°C until analysis. 
Total cholesterol, high density lipoprotein (HDL)-
cholesterol and triglycerides were analyzed using 
calorimetric kit methods (RANDOX, UK). The 
concentration of low density lipoprotein (LDL)-cholesterol 
was calculated using the Friedwald formula. 
Mean values have been presented as means ± 
Table 1. Demographic and clinical characteristics of AMI patients 
(n=451). 
Variable Value 
(mean ± SD) 
Frequency (%) 
Age (years) 
Gender 
54.3 ± 10.7 
Male 341 (75.6) 
Female 110 (24.4) 
BMI (kg/m2) 25.0 ± 4.1 
>25 189 (43.8) 
Hypertensive 
	 Yes 243 (57.4) 
No 180 (43.6) 
Diabetic 	 Yes 153 (34.6) 
No 289 (65.4) 
Glucose (mg/dl) 137 ± 76 
Cholesterol (mg/dl) 181 	 50 
Triglycerides (mg/di) 177± 127 
HDL-cholesterol (mg/dl) 35.7 ± 11.3 
LDL-cholesterol (mg/di) 110±47 
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standard deviation (SD). Univariate and multivariable 
analyses were carried out using the SPSSt (statistical 
package for social sciences) Software Version 10 for 
Windows® to study the effect of various factors on lipid 
levels. Independent sample t-test, chi-square test and 
simple linear regression were used to test the significance at 
the univariate level. Multiple linear regression was used to 
test the significance at multivariable level. All variables 
with p-value <0.2 were considered for multivariable 
analysis. For comparison of lipid levels in younger and 
Table 2. Effect of age, gender, BMI, diabetes mellitus, hypertension 
older groups, the patients were divided into those above 50 
years and those below 50 years. This cut off age of 50 years 
was chosen to exclude the effect of female sex hormones on 
lipid levels in older females, because the usual age of 
menopause in female population is considered to be about 
49 years. A p-value of <0.05 was considered significant. 
Results 
Table 1 shows the demographic and clinical 
characteristics of patients. There were 341 males and 110 
and smoking on serum levels of lipids in AMI patients (mean ±SD). 
Factors 
	 Numbera 
Total cholesterol 
Lipid concentration (mg/di) 
HDL-cholesterol 
	 LDL-cholesterol Triglycerides 
Age (years) 
<50 
>50 
187+52 
177+48 
(p value 0.055) 
35.6+10_8 
35.7+11.68 
(p value 0.911) 
111+51 
110+44 
(p value 0.942) 
194+137 
166+109 
(p value 0.019)* 
279 
171 
Gender 
Male 
Female 
BM1 (kg/m2) 
<25 
>25 
Diabetes 
Yes 
No 
Hypertension 
Yes 
No 
Smokingb 
Yes 
No 
341.  
110 
243 
189 
153 
289 
243 
180 
123 
203 
179+48 
187+54 
(p value 0.113) 
177+48 
185+51 
(p value 0.077) 
186+51 
177+49 
(p value 0.082 
179+47 
181+52 
(p value 0.695) 
184+53 
181+48 
(p value 0.639) 
35.3+11.2 
36.8+11.8 
(p value 0.253) 
35.5+11.7 
36.2+11.0 
(p value0.514) 
34.2+9.8 
36.3+12.2 
(p value 0.089) 
35.2+11.7 
36.3+11.2 
(p value 0.385) 
34.2+11.2 
35.0+10.3 
(p value 0.51) 
109+45 
114+54 
(p value0.324) 
106+44 
114+50 
(p value 0.082) 
116+49 
106+45 
(p value 0.050)* 
109+47 
108+46 
(p value 0.748) 
111+49 
113+46 
(p value 0.723 
174+124 
184+111 
(p value 0.472) 
168+123 
187+119 
(p value 0.120) 
183+111 
175+128 
(p value 0.515) 
175+120 
183+128 
(p value 0.532) 
176+111 
175+122 
(p value 0.906) 
*Significant at p<0.05 
a = Discrepancy in total number for certain factors (being less than 451) is due to some missing information. 
b = Those who had quitted smoking or were occasional smokers were not included. 
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females. Mean age of the group was 54.3 ± 10.7 years with 
range 30-75 years. Mean BMI was 25 f 4.1 kg/m2. Mean 
value of fasting serum glucose was 137 ± 76 mg/d1. Thirty 
five percent of patients were diabetic, 57% were 
hypertensive, while 43.8% were overweight/obese (BMI 
>25). Mean values of serum total cholesterol, triglycerides, 
HDL-cholesterol and LDL-cholesterol were 181 ± 50 
mg/dl, 177 ± 127 mg/di, 35.7 ± 11.3 mg/dl, and 110 ± 47 
mg/di, respectively. 
"low HDL-cholesterol" and "isolated low HDL-cholesterol" 
shown in Table 3. The frequencies of hypercholesterolemia, 
hypertriglyceridemia, "low HDL-cholesterol" and "isolated 
low HDL-cholesterol" were found to be 30.6%, 30.10/, 
48.6% and 34.1%, respectively. A comparison of 
percentages in the male and female groups using chi square 
revealed statistically significant difference only in the low 
HDL-cholesterol (p=0.04) group. 
Table 3. Prevalence of hypercholesterolemia, hypertriglyceridemia, low HDL-cholesterol and isolated low HDL-cholesterol in AM1 patients. 
Variable 
Males 
(n=341) 
Frequency (%) 
Females 
(n=110) 
Total 
(n=451) 
13-value* 
Hypercholesterolemia 
(>200mg/dI) 
Hypertriglyceridemia 
(>200 mg/dl) 
Low HDL-cholesterol 
(<35 mg/dl) 
Isolated low-HDL-
cholesterol(HDL<40 mg/dI 
and TG <150 mg/dl) 
98 (28.7) 
99 (29) 
174 (51) 
121 (35.5) 
40 (36.4) 
37 (33.6) 
45 (40.1) 
33 (30) 
138 (30.6) 
136 (30.1) 
219 (48.6) 
154 (34.1) 
0.13 
0.36 
0.04 
0.29 
*P-value compares percentages in male and female groups and is based on test of association using chi square. 
Table 2 shows the effect of age, gender, BMI, 
diabetes mellitus, hypertension and smoking on serum 
levels of total cholesterol, HDL-cholesterol, LDL-
cholesterol and triglycerides in AMI patients. Mean 
concentrations of total cholesterol and HDL-cholesterol 
were not significantly affected by age, gender, BMI, 
diabetes mellitus, hypertension and smoking. Mean LDL-
cholesterol level, however, was found to be significantly 
increased in diabetes mellitus (p=0.047), while age, gender, 
BMI, hypertension and smoking had little effect on the level 
of this lipoprotein. Mean levels of triglycerides were 
significantly decreased in older patients (>50 years) 
compared to younger (<50 years) ones (p=0.019). Gender, 
BMI, diabetes, hypertension and smoking had no significant 
effect on triglyceride levels in these patients. Multivariable 
analysis of the data to see the combined effect of these 
factors revealed no significant association between any of 
these factors and the lipid levels in AMI patients. 
Prevalence of hypercholesterolemia, hypertriglyceridemia, 
Discussion 
Pakistanis belong to an ethnic group which has the 
highest rates of CAD.3 
 According to a recent estimate based 
on scientific studies, nearly 100,000 individuals suffered an 
AM1 in Pakistan in the calendar year 2002.7 Lehto et al. 
have demonstrated direct correlations between the 
incidence of AMI and plasma lipid abnormalities.8 There 
are only few reports on lipid profile of Pakistani AMI 
patients. A small study (n=31) carried out by Salahuddin et 
al. revealed significantly high levels of triglycerides and 
significantly low levels of HDL-cholesterol in AMI patients 
compared to normal controls.6 
 This was suggestive of an 
important role played by lipid abnormalities in the 
development of atherosclerosis in our population. Our 
results compare well with the baseline levels of lipids 
reported in two other studies.5.6 
The high levels of triglycerides in coronary heart 
disease (CHD) have also been reported among Indians by 
547 
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Gupta et al.9 
 and among Egyptians by Metwalli et al.10 The 
increased levels of triglycerides in Pakistani, Indian and 
Egyptian AMI patients could be due to their genetic makeup 
and nutritional habits involving high consumption of 
saturated fats.11,12 
Our results show that hypertension has no effect on 
lipid levels in our patients (Table 2). This is suggestive that 
the factors leading to hypertension have little effect on the 
lipid profile in AMI patients. Similarly, diabetes mellitus 
also appears to have no significant effect on levels of total 
cholesterol, HDL-cholesterol and triglycerides in AMI 
patients. There was, however, an increase in LDL-
cholesterol. Although, smoking is known to affect serum 
lipid levels, especially a decrease in the HDL-
cholestero113,14 
 yet in the present study it did not appear to 
have any significant impact on lipid profile in AMI patients. 
This lack of association observed by us could have been due 
to the absence of information regarding the frequ'ency and 
duration (number of years) of smoking by the patients. 
Thirty one percent of our patients had 
hypercholesterolemia (Table 3). This frequency compares 
well with 37% reported by Ishaq et al. in a recent study.15 It 
is noteworthy that the baseline mean HDL-cholesterol 
levels in our patient population are well below the normal 
levels (40 mg/di) recommended by the National Cholesterol 
Education Program16, indicating that low levels of HDL-
cholesterol in our AMI patients may have contributed to 
their accelerated coronary atherosclerosis resulting into 
AMI. 
In fact, the prevalence of "low HDL-cholesterol" 
(<35 mg/dl) in our population of patients (48.6%) was 
among the highest in the world (Table 3) as compared to 
other studies done internationally.9,17-19 
Similarly the prevalence of "isolated low-HDL-
cholesterol" (HDL <40 mg/dl and triglycerides <150 mg/dl) 
in our AMI patients was found to be 34.1% (Table 3) which 
is very high compared to
. 
 its frequency in other 
populations.17 
Hypertriglyceridemia appears to be a prominent 
feature in CHD. In our study, its prevalence in AMI patients 
was found to be 30% which is higher as compared to a study 
in a Caucasian population of CAD patients in Boston.19 
In conclusion, our data confirms the previous 
observations that high levels of triglycerides and low levels 
of HDL-cholesterol are the most prominent lipid 
abnormalities in Pakistani AMI patients. These two lipids 
abnormalities constitute an important component of 
"metabolic syndrome" known as "atherogenic 
dyslipidemia".20 
 This syndrome, which in addition to 
atherogenic dyslipidemia, also includes abdominal obesity, 
elevated blood pressure, insulin resistance, a proinflammatory 
state and a prothrombotic state poses a significant health risk 
to individuals and is a growing health crisis for our country. 
Our dietary habits could have contributed to this 
atherogenic dyslipidemia in AMI patients. Decreased serum 
HDL-cholesterol is considered to be one of the most 
common lipid disorders in AMI patients.8 The mechanisms 
responsible for this change may reside in the decreased 
synthesis and secretion of HDL-cholesterol from liver 
and/or accelerated elimination from the blood stream by 
extravasation. Increased permeability of the capillary 
membranes during the acute inflammation after AMI has 
been shown to cause extravasation of HDL-cholestero1.21 A 
focus on the strategies to decrease triglyceride levels and 
increase HDL-cholesterol levels in CAD patients, such as 
cessation of smoking13 
 and use of low-fat diet which is high 
in polyunsaturated fatty acids22,23 
 decreased consumption of 
ghee (which has high proportion of saturated fars and trans 
fatty acids)24, will greatly help in reducing future coronary 
events in them. 
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The Onset and Duration of Benefit from Counselling by minimally Trained 
Counsellors on Anxiety and Depression in Women 
A. Gul, B. S. Ali* 
Departments of Community Health Sciences and Family Medicine*, Aga Khan University, Karachi. 
Abstract 
Objective: To assess the onset and duration of benefit of counselling by minimally trained community 
counsellors on level of anxiety and/or depression in women of their own community. 
Method: A randomized controlled trial for assessing the effectiveness of 4 and 8 weeks of counselling by 
minimally trained community women in reducing the levels of anxiety and depression was carried out in a lower 
middle class, semi-urban community in Karachi, Pakistan. In the baseline survey, 366 anxious and/or depressed 
women were identified and randomized to intervention and control arms. The intervention arm was re-screened 
for anxiety and depression after 4 and 8 weeks of counselling and again 8 weeks after the last counselling 
session. As the results showed a significant benefit in the intervention arm, for ethical reasons the controls were 
also counselled; and were screened in the same way. This study is a sub-analysis from the RCT specifically 
looking at the onset and the duration of benefit. 
Results: A significant reduction in the mean scores of both the groups was found after 4 weeks of counselling 
which further improved at 8 weeks. The gradient of improvement was steeper at 4 weeks. At 8 weeks post 
counselling some loss of effect was detected but the levels still remained below the initial mean score. 
Conclusion:. This study indicates that literate women from semi urban communities can be trained as 
counsellors and their counselling can lead to a significant benefit in just 4 counselling sessions of 1 hour each, 
and could last at least till 8 weeks after the last session. Keeping in view the current high prevalence, the 
available facilities for treatment and the stigma attached to psychiatric treatment in our communities; this 
modality of intervention at the PHC level could be an alternative strategy for the management of depression (JPMA 54:549;2004). 
Introduction 
Counselling and psychotherapy have evolved as 
forms of interventions for anxiety and depression.1,2 Brief 
psychotherapy or cognitive behavior therapy is being widely 
used in general practice, and patients referred to counsellors 
have shown a statistically significant improvement 
compared to those receiving treatment from general 
practitioners only.3.4 
 Controlled trials have shown that  
cognitive behavioral therapy and interpersonal 
psychotherapy have achieved results comparable to 
antidepressants5-1 
 and the delay in the onset of benefit is the 
same for both interventions.8 
 Several attempts have been 
made to assess the persistence of the gains after different 
intervals of having stopped psychotherapy/counselling.9-12 
A relapse rate after 1 year of stopping pharmacotherapy is 
being reported as 80% and that after cognitive behaviour 
therapy is saidto be 25%. It is being said that these findings 
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